Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
01/2004
01/27/2004US6683173 Tm leveling methods
01/27/2004US6683172 Composition for inhibiting inflammatory response comprising at least one nucleic acid molecule selected from specified sequences
01/27/2004US6683171 Contacting fkhsf specific nucleic acid probe under high stringency hybridizing conditions with at least one nucleic acid molecule from biological sample, detecting formation of hybrid, indicating presence of fkhsf nucleic acid molecule
01/27/2004US6683166 Modified internucleoside linkages (ii)
01/27/2004US6683165 Human gene relating to respiratory diseases and obesity
01/27/2004US6683160 Antibodies specific for Fkhsf gene products
01/27/2004US6683157 Variant human α7 acetylcholine receptor subunit, and methods of production and use thereof
01/27/2004US6683156 Method for diagnosing selected adenocarcinomas
01/27/2004US6682942 Microdevices for screening biomolecules
01/27/2004US6682906 Cloned glutamic acid decarboxylase
01/27/2004US6682904 Detecting a decrease in hyal2 activity due to contact with the test agent, wherein the test agent does not substantially affect activity of an anti-inflammatory hyaluronidase, thereby identifying an agent that specifically inhibits hyal2 activity
01/27/2004US6682902 Human extracellular matrix polypeptides; polynucleotides; expression vectors; host cells; medical diagnosis; prostate cancer; detection of metastasis
01/27/2004US6682901 Detecting cancer in humans; obtain cells, incubate with cadherins, monitor binding
01/27/2004US6682899 Apparatus and method for detecting and identifying infectious agents
01/27/2004US6682895 Nanoparticles having oligonucleotides attached thereto and uses therefor
01/27/2004US6682893 Generating layered sols; provide sol layer, generate voids in layer, provide second sol layer in voids, remove first sol layer, monitor layout
01/27/2004US6682892 Screening for modulator of viral infectivity; obtain modulator, incubate with virus, monitor infectivity of virus
01/27/2004US6682890 Methods of diagnosing and determining prognosis of colorectal cancer
01/27/2004US6682889 Amplification and detection of organisms of the Chlamydiaceae family
01/27/2004US6682888 Genes expressed in alzheimer's disease
01/27/2004US6682887 Snp detection sequences bound to target dna are partially degraded with release of said electrophoretic tag, each released product produced from a given detection sequence has a known, unique electrophoretic mobility
01/27/2004US6682886 Bivalent binding molecules of 7 transmembrane G protein-coupled receptors
01/27/2004US6682885 Method for detecting mutations using an URA3 reporter gene
01/27/2004US6682884 Method and device for the rapid clinical diagnosis of hepatitis B virus (HBV) infection in biological samples
01/27/2004US6682883 Chimeric virus comprises nucleic acid sequences derived from predetermined flavivirus structural genes prm-e, the other a flavivirus used as chimera backbone; inoculating mammal with chimeric virus for animal model of infection
01/27/2004US6682648 Electrochemical reporter system for detecting analytical immunoassay and molecular biology procedures
01/27/2004CA2309450C Nanoelectrode arrays
01/27/2004CA2258489C High-throughput screening assay systems in microscale fluidic devices
01/27/2004CA2236070C Electrochemical biosensor
01/27/2004CA2146207C Assay method and device
01/27/2004CA2080428C A method for preparing a thromboplastin reagent from cultured cells that is suitable for use in the prothrombin time test
01/27/2004CA2021489C Methods and compositions for chromosome-specific staining
01/23/2004CA2433473A1 Fluorescent hybridization probes with reduced background
01/22/2004WO2004008480A2 Quantitative analysis via isotopically differentitated derivatization
01/22/2004WO2004008371A1 Peptide and protein identification method
01/22/2004WO2004008279A2 Computer user interface facilitating acquiring and analyzing of biological specimen traits
01/22/2004WO2004008148A1 Method for detection of bioactive peptides
01/22/2004WO2004008147A2 Diagnosis and prevention of cancer cell invasion
01/22/2004WO2004008144A2 Method capable of being automated for detection of prpres and uses thereof
01/22/2004WO2004008130A1 Enzyme electrodes and method of manufacture
01/22/2004WO2004008105A2 Detection of ligand/antiligand complex formation by electromagnetically detectable bulk property measurement
01/22/2004WO2004007773A1 Multiplex genotyping using solid phase capturable dideoxynucleotides and mass spectrometry
01/22/2004WO2004007771A1 Nucleic acid pre-absorption assay
01/22/2004WO2004007770A2 Method for diagnosis of intestinal-type gastric tumors
01/22/2004WO2004007769A1 Method of screening remedy for aids
01/22/2004WO2004007768A1 Method to analyze polymeric nucleic acid sequence variations
01/22/2004WO2004007767A2 Serrs reactive particles
01/22/2004WO2004007766A1 Nucleic acid amplification method
01/22/2004WO2004007765A1 Polymorphisms in the equine tnf-alpha gene
01/22/2004WO2004007764A2 Chromosome 3, 5 and 11 genes involved in premature canities
01/22/2004WO2004007763A2 Method and means for quantitative analysis of the number of molecules coding for different genes in cells
01/22/2004WO2004007762A2 Genes associated with schizophrenia, adhd and bipolar disorders
01/22/2004WO2004007761A1 Method to reduce false positive outcomes in prion tests
01/22/2004WO2004007760A1 Method of decomposing protein with sulfonic acid compound
01/22/2004WO2004007759A2 Identification method for verifying the authenticity of an object
01/22/2004WO2004007758A1 Novel method of selecting immunosuppressant having little thrombocytopenic effect
01/22/2004WO2004007757A1 Method for identifying individual active entities from complex mixtures
01/22/2004WO2004007756A1 Minimising calibration problems of in vivo glucose sensors
01/22/2004WO2004007755A2 Multiplex nucleic acid reactions
01/22/2004WO2004007752A2 System and method for determining known dna variants with temperature gradient electrophoresis
01/22/2004WO2004007751A2 Nucleic acid labeling methods
01/22/2004WO2004007747A2 Assays for assembly of ebola virus nucleocapsids
01/22/2004WO2004007746A2 METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE IL-4 RECEPTOR-MEDIATED IgE SYNTHESIS UTILIZING A B-CELL ASSOCIATED PROTEIN
01/22/2004WO2004007745A2 Method for chemiluminescent detection
01/22/2004WO2004007742A2 Chromosome 6 and 9 genes involved in premature canities
01/22/2004WO2004007726A2 Brachyspira hyodysenteriae vaccine
01/22/2004WO2004007723A2 Genes
01/22/2004WO2004007722A2 Transgenic animal expressing alzheimer’s tau protein
01/22/2004WO2004007718A2 Rna-interference by single-stranded rna molecules
01/22/2004WO2004007710A1 Solid support having electrostatic layer and use thereof
01/22/2004WO2004007708A1 Modulation of cytochrome p450 reductase activity
01/22/2004WO2004007706A1 Plant nucleotide-sugar pyrophosphatase/phosphodiesterase (nppase), method of obtaining same and use of same in the production of assay devices and in the production of transgenic plants
01/22/2004WO2004007701A1 Transplant acceptance inducing cells of monocytic origin and their preparation and use
01/22/2004WO2004007696A2 Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
01/22/2004WO2004007692A2 Methods and compositions for analyzing polymers using chimeric tags
01/22/2004WO2004007690A2 Method and system for comparative genomics for organisms using temperature gradient electrophoresis
01/22/2004WO2004007684A2 Synthetic tag genes
01/22/2004WO2004007681A2 Genetic susceptibility genes for asthma and atopy and asthma-related and atopic-related phenotypes
01/22/2004WO2004007677A2 In vitro transcription assay for t box antitermination system
01/22/2004WO2004007675A2 Neuronal and optic nerve gene expression patterns
01/22/2004WO2004007674A2 Neuronal and retinal gene expression patterns
01/22/2004WO2004007673A2 Neuronal gene expression patterns
01/22/2004WO2004007667A2 Polynucleotide and polypeptide fat metabolism regulators and uses thereof
01/22/2004WO2004007664A2 Nucleic acid vectors
01/22/2004WO2004007547A2 Truncated tau proteins
01/22/2004WO2004007546A1 Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases
01/22/2004WO2004007531A2 Activated checkpoint therapy and methods of use thereof
01/22/2004WO2004007078A1 Lateral flow assay device and method
01/22/2004WO2004006985A2 Assaying and imaging system identifying traits of biological specimens
01/22/2004WO2004006952A2 Therapeutic tuberculosis vaccines
01/22/2004WO2004006866A2 Antifungal therapeutic targets
01/22/2004WO2004006854A2 Method for identification of biologically active agents
01/22/2004WO2004006852A2 Method for selectively inhibiting fungal growth
01/22/2004WO2004006832A2 Methods and compounds for reducing biofilm formation
01/22/2004WO2004006753A2 Sga-72m, a cancer associated antigen, and uses thereof
01/22/2004WO2003103480A3 Gene cluster analysis for coronary artery disease
01/22/2004WO2003102143A3 HUMAN COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1 (hCARM1)
01/22/2004WO2003099104A3 Elisa assay of serum soluble cd22 to assess tumor burden/relapse in subjects with leukemia and lymphoma
01/22/2004WO2003097665A3 Mid 241 receptor, a novel g-protein coupled receptor
01/22/2004WO2003093495A3 Diffraction-based diagnostic devices